Quantcast

Latest Syndromes Stories

2014-08-13 08:28:26

-- Keynote Speaker: Mark Pimentel, M.D., FRCP(C), Director, GI Motility Program and Laboratory, Cedars-Sinai Medical Center; Chairman, Synthetic Biologics' C-IBS Clinical Advisory Board -- ROCKVILLE, Md., Aug. 13, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that it will host an Investor Day in...

2014-08-12 11:10:06

Wiley Readmissions more likely in black and Hispanic systemic lupus erythematosus patients A new study reveals that one in six patients with systemic lupus erythematosus (SLE) is readmitted to the hospital within 30 days of being discharged. Results published in Arthritis & Rheumatology, a journal of the American College of Rheumatology (ACR), show that black and Hispanic SLE patients were more likely to be readmitted than white patients. Readmissions among patients insured by...

2014-08-12 08:31:24

Discounts are now available on IBS medications like Linzess or Amitiza allow patients to regain their quality of life MARGATE, N.J., Aug. 12, 2014 /PRNewswire-iReach/ -- Irritable Bowel Syndrome (IBS) may not sound serious, but for the roughly 15% of Americans who have to cope with it on a daily basis, it is anything but frivolous. The gastrointestinal tract makes up most of the human digestive system. When it isn't functioning properly, the result can be a host of uncomfortable...

2014-08-10 23:01:29

Filling the need for continuing education in the use of MyoFascial trigger point therapy to alleviate pain related to the muscular system, Hands-On Seminars will be offering their intensive training in this technique on location in Afton, Wyoming to physical therapy professionals. Astoria, New York (PRWEB) August 10, 2014 Laura is a mother of 3 with a full time job. “Working in a supermarket is very physically demanding, and my lower back suffers,” says Laura. During the past two...

2014-08-08 11:12:02

AGA Immunosuppressive drugs called thiopurines have been found to increase the risk of myeloid disorders, such as acute myeloid leukemia and myelodysplastic syndrome, a rare bone marrow disorder, seven-fold among inflammatory bowel disease (IBD) patients. These data were reported in a new study1 published in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association (AGA). Thiopurines are an established treatment for...

2014-07-31 16:29:24

AZ-002 Phase 2a Study in Patients with Epilepsy Planned for Second Half of 2014 MOUNTAIN VIEW, Calif., July 31, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today provided an update on its pipeline and new product development efforts. In the second half of 2014, Alexza expects to initiate a Phase 2a study of AZ-002 (Staccato(®) alprazolam), which is being developed for the management of patients with acute repetitive seizures. Additionally, Alexza has...

2014-07-30 23:02:12

EDNF Installs 2014-2015 Board of Directors McLean, VA (PRWEB) July 30, 2014 The Ehlers-Danlos National Foundation (EDNF) is pleased to announce its 2014-2015 Board of Directors. Sandra Aiken Chack will serve as chair. The board was voted upon earlier this month at the EDNF 2014 Annual Learning Conference in Houston, Texas July 10-12. “The Ehlers-Danlos National Foundation has an ambitious agenda ahead of us. From the rollout of the first EDNF Center for Clinical Care & Research at...

2014-07-23 12:31:13

MELBOURNE, Australia, July 23, 2014 /CNW/ - The Honourable Rona Ambrose, Minister of Health, participated in the 20(th) International AIDS Conference this week in Melbourne, Australia. During the Conference sessions, meetings and side events, Minister Ambrose reinforced Canada's continued commitment to global efforts to address HIV/AIDS and to advancing a comprehensive and integrated long-term approach to address HIV/AIDS in Canada. While in Melbourne, Minister Ambrose toured the...

2014-07-23 08:32:06

ATLANTA, July 23, 2014 /PRNewswire/ -- PCOS Challenge announces its annual PCOS Awareness Symposium in the Atlanta, Georgia metro area on Sunday, September 21, 2014. The event will feature some of the world's leading Polycystic Ovary Syndrome experts, and bring together clinicians, researchers and hundreds of patients for a day of sharing experiences, insights and the latest updates about PCOS. Photo - http://photos.prnewswire.com/prnh/20140722/129570 Photo -...

2014-07-23 08:30:41

Strengthens Leadership Position in Treatments for Hunter syndrome and Commitment to MPS II Patient Community LEXINGTON, Massachusetts, July 23, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty biopharmaceutical company, and ArmaGen, a US privately held biotechnology company, today announced a worldwide licensing and collaboration agreement for AGT-182, an investigational enzyme replacement therapy (ERT) for the potential treatment of both the...


Latest Syndromes Reference Libraries

Marfan's Syndrome
2013-07-19 15:22:33

Marfan's syndrome is a genetic disorder of the connective tissue that causes excessively tall stature and long extremities. It is carried by the gene FBN1, which encodes the connective protein fibrillin-1, and is a dominant trait. The human genetic makeup contains a pair of FBN1 genes, so because of its dominance, inheriting one affected FBN1 gene from either parent will result in Marfan's syndrome. It effects both males and females, and has no ethnic bias. It was named after Antoine Marfan,...

More Articles (1 articles) »
Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.